Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Low dose combination therapy for treatment of myeloproliferative neoplasms

Low dose combination therapy for treatment of myeloproliferative neoplasms

US Patent 11278541 · Granted Mar 22, 2022

Estimated economic value: $113,457,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

BRD4-JAK2 inhibitors2025
Combination therapy comprising AXL/MER and PD-1/PD-L1 inhibitors2025
BRD4-JAK2 inhibitors2025
Combination therapy comprising an FGFR inhibitor and a Nectin-4 targeting agent2024
Low dose combination therapy for treatment of myeloproliferative neoplasms2020
Low dose combination therapy for treatment of myeloproliferative neoplasms2020
Potent dual BRD4-kinase inhibitors as cancer therapeutics2020
Method of detecting oncogenesis of hematopoietic cells2013
Methods and compositions for enhancing the immunostimulatory effect of interleuk2002